FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+13.35%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$216M
AUM Growth
+$216M
(+8.9%)
Cap. Flow
-$4.83M
Cap. Flow
% of AUM
-2.24%
Top 10 Holdings %
Top 10 Hldgs %
44.96%
Holding
70
New
3
Increased
13
Reduced
28
Closed
5
Top Buys
| 1 |
MODN
MODEL N, INC.
MODN
|
$5.3M |
| 2 |
AKRX
Akorn, Inc.
AKRX
|
$4.76M |
| 3 |
Option Care Health
OPCH
|
$4.56M |
| 4 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$4.38M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
$2.35M |
Top Sells
| 1 |
NeoGenomics
NEO
|
$8.56M |
| 2 |
ELGX
Endologix Inc
ELGX
|
$3.39M |
| 3 |
AngioDynamics
ANGO
|
$3.36M |
| 4 |
LDRH
LDR HOLDINGS CORP COM STK
LDRH
|
$2.74M |
| 5 |
Arrowhead Research
ARWR
|
$2.37M |
Sector Composition
| 1 | Healthcare | 74.24% |
| 2 | Energy | 4.55% |
| 3 | Communication Services | 2.46% |
| 4 | Real Estate | 1.52% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOC
26
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.27M | 1.52% |
155,849
-2,373
| -1% | -$49.9K |
|
|
ELGX
27
DELISTED
Endologix Inc
ELGX
| $3.22M | 1.49% |
258,431
-271,698
| -51% | -$3.39M |
|
|
CYNA
28
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $3.16M | 1.46% |
188,577
-3,403
| -2% | -$57K |
|
|
BLUE
29
DELISTED
bluebird bio
BLUE
| $2.9M | 1.34% |
67,044
-1,063
| -2% | -$46K |
|
30
Veracyte
VCYT
$2.41B
| $2.75M | 1.27% |
546,021
-10,444
| -2% | -$52.5K |
|
31
Bio-Techne
TECH
$8.3B
| $2.72M | 1.26% |
24,146
-360
| -1% | -$40.6K |
|
32
Alkermes
ALKS
$4.95B
| $2.68M | 1.24% |
62,068
-1,160
| -2% | -$50.1K |
|
|
TEAR
33
DELISTED
TearLab Corporation
TEAR
| $2.41M | 1.12% |
3,760,430
+14,267
| +0.4% | +$9.13K |
|
|
IMMU
34
DELISTED
Immunomedics Inc
IMMU
| $2.29M | 1.06% |
987,854
-555,688
| -36% | -$1.29M |
|
|
STRM
35
DELISTED
Streamline Health Solutions
STRM
| $2.15M | 1% |
1,792,041
+35,653
| +2% | +$42.8K |
|
36
Vertex Pharmaceuticals
VRTX
$102B
| $2.05M | 0.95% |
23,835
-441
| -2% | -$37.9K |
|
|
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
| $1.98M | 0.92% |
554,841
+28,571
| +5% | +$102K |
|
|
CPHD
38
DELISTED
Cepheid Inc
CPHD
| $1.91M | 0.89% |
62,178
-1,160
| -2% | -$35.7K |
|
39
QuidelOrtho
QDEL
$1.87B
| $1.5M | 0.69% |
83,698
-64,639
| -44% | -$1.15M |
|
|
NSTG
40
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.49M | 0.69% |
+118,547
| New | +$1.49M |
|
41
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.44M | 0.67% |
18,515
-340
| -2% | -$26.4K |
|
|
AET
42
DELISTED
Aetna Inc
AET
| $637K | 0.3% |
5,215
| – | – |
|
43
Humana
HUM
$37.5B
| $637K | 0.3% |
3,540
| – | – |
|
44
Bristol-Myers Squibb
BMY
$96.7B
| $610K | 0.28% |
8,290
| – | – |
|
45
Becton Dickinson
BDX
$54.3B
| $576K | 0.27% |
3,395
| – | – |
|
46
Elevance Health
ELV
$72.4B
| $538K | 0.25% |
4,095
| – | – |
|
47
Novartis
NVS
$248B
| $501K | 0.23% |
6,070
| – | – |
|
|
AGN
48
DELISTED
Allergan plc
AGN
| $470K | 0.22% |
2,035
| – | – |
|
49
Johnson & Johnson
JNJ
$429B
| $463K | 0.21% |
3,820
| – | – |
|
|
AGRX
50
DELISTED
Agile Therapeutics, Inc
AGRX
| $454K | 0.21% |
59,701
-1,768
| -3% | -$15.1K |
|